维普中文期刊产品整合服务
13篇 您的检索式:作者名="Pelzer U"
    题名 作者 年代 出处 被引量
1Rationale and design of PROS- PECT- CONKO 004:a prospective, randomized trial of simultane- otis pancreatic cancer treatment with enoxaparin and chemothera py显示文摘Riess H Pelzer U Hilbig A 2008BMC Cancer2008,8,:1
2Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy 显示文摘RIESS H PELZER U HILBIG A 2008BMC Cancer2008,,8:1
3A prospective,randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC):Results of the CONKO 004 trial显示文摘Riess H Pelzer U Deutschinoff G 0,,15:1
4Oxaliplatin/folinic acid/5-fluorouracil (OFF) plus best supportive careversus best supportive care alone (BSC) in secondline therapy ofgemcitabine-refractory advanced pancreatic cancer (CONKO 003)显示文摘Oettle H Pelzer U Stieler J 2005J Clin Oncol2005,23,16:1
5A prospective,randomized trial of chemotherapy with or without the low molecular weight heparin(LMWH)enoxaparin in patients (pts)with advanced pancreatic cancer (APC):results of the CONKO 004 trial显示文摘Riess H Pelzer U Deutschinoff G 2009J Clin Oncol2009,27,18:1
6Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer-the CONKO 004 pilot trial显示文摘Pelzer U Hilbig A Stieler JM 2014BMC Cancer2014,14,:1
7Best supportive care ( BSC ) versus oxaliplatin ,folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase Ⅲ- study from the German CONKO-study group 显示文摘Pelzer U Schwaner I Stieler J 2011Eur J Cancer2011,47,11:1
8Rationale and design of PROSPECT-CONKO 004 : a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy显示文摘Riess H Pelzer U Hilbig A 2008BMC Cancer2008,8,:1
9Oxaliplatin/folinic acld/5-fluorouracil (OFF) plus best supportive care versus bestsupportive care alone ( BSC ) in second-line therapy of gemcit-abine-refractory advanced pancreatic cancer ( CONKO 003 ) 显示文摘Oettle H Pelzer U Stieler J 2005Proc Am Soc Clin Oncol2005,24,:1
10Oxaliplatic/folinic acid/5-fluorouracil plus best supportive care versus best supporlive care alone (BSC) in seeond-line therapy of gemcitabine-refractory advanced pancreatic cancer 显示文摘Oettle H Pelzer U Stieler J 2005J Clin Oneol2005,23,16:1
11Results of a phase Ⅱ study显示文摘Pelzer U Arnold D Goevercin M Stieler J Doerken B Riess H Oettle H:Parenteral nutrition support for patients with pancreatic cancer 2010BMC cancer2010,10,:1
12A prospective, ran- domized trial of chemotherapy with or without the low molecular weight heparin ( LMWH ) enoxaparin in patients ( pts ) with ad- vanced pancreatic cancer(APC) : results of the CONKO 004 trial显示文摘Riess H Pelzer U Deutschinoff G 2009J Clin Oteol2009,27,18:1
13Best supportive care ( BSC ) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase Ill-study from the German CONKO-study group显示文摘Pelzer U Schwaner I Stieler J 2011Eur J Cancer2011,47,11:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费